Privia Health Group, Inc. (PRVA) Tops Q3 EPS by 24c; raises guidance
Privia Health Group, Inc. (NASDAQ: PRVA) reported Q3 EPS of $0.29, $0.24 better than the analyst estimate of $0.05. Revenue for the quarter came in at $580.4 million versus the consensus estimate of $492.21 million.
GUIDANCE:
Privia Health Group, Inc. sees FY2025 revenue of $2.05-2.1 billion, versus the consensus of $2.003 billion.
For earnings history and earnings-related data on Privia Health Group, Inc. (PRVA) click here.
